Actual Strategies in the Treatment of Severe Burns - Considering Modern Skin Substitutes

Abstract

Early wound closure enables a better prognosis with regard to survival and outcome in severe burn injuries. Even so, the treatment of extended 2^nd degree thermal traumas is well discussed. A conservative procedure with daily changes of dressings and application of topical antimicrobial creams is uncomfortable for patients and staff. In addition, there is a higher risk of severe infection. Meanwhile, early debridement and temporary wound coverage is established as state of the art also in 2^nd degree burns. Many biological and textile materials are already in use. The newly designed resorbable polylactide-membrane Suprathel^® seems to be a good alternative material. We have proved that Suprathel^® significantly reduces pain. The handling of Suprathel^® is very easy. This retrospective study of our patients with severe thermal injuries shows that primarily the majority of burn victims were treated with Suprathel^®. Only few patients required an additional grafting even in cases with extended burn areas. The frequency of grafting procedures could be reduced considerably. But also patients with extended 3^rd degree burn areas requiring an early skin grafting had a benefit from the application of Suprathel^® on donor sites and all tangential necrotic areas. Encouraged by this success, we established a new two-step concept for the treatment of severe thermal injuries. This strategy seems to be suitable also for burn centres with low financial resources, because expensive tissue engineering therapies are reduced to a minimum by this concept.

Severe thermal injuries - early wound closure - temporary skin substitutes - resorbable polylactide membrane - Suprathel^® - retrospective study - new strategy for treatment

References

• 1 Barret JP, Dziewulski P, Ramzy PI, Wolf SE, Desai MH, Herndon DN. Biobrane vs. 1% silver sulfadiazine in second degree pediatric burns.  Plast Reconst Surg. 2000;  105 62-65
• 2 Barret JP, Dziewulski P. Management of Superficial Burns. In: Barret-Nerín JP, Herndon DN (eds.). Principles and Practice of Burn Surgery. Marcel Dekker, New York 2005: 163-186
• 3 Cristofoli C, Lorenzini M, Furlan S. The use of Omiderm^®, a new skin substitute, in a burn unit.  Burns Incl Therm Inj. 1986;  12 587-591
• 4 Demling RH. Use of Biobrane^® in the management of scalds.  J Burn Care Rehabil. 1995;  16 329-330
• 5 Druecke D, Steinstraesser L, Homann HH, Steinau HU, Vogt PM. Current indications for glycerol-preserved allografts in the treatment of burn injuries.  Burns. 2002;  28 26-30
• 6 Fox CL. Silver sulfadiazine: a new topical therapy for Pseudomonas in burns.  Arch Surg. 1968;  96 184-188
• 7 Fuller F, Engler P. Leukopenia in non-septic patients receiving 1% silver sulfadiazine cream treatment: a survey.  J Burn Care Rehabil. 1989;  9 606-609
• 8 Hartmann B, Küntscher M, Uhlig Chr, Hierlemann H, Schwarze H. Suprathel^®, a new skin substitute, in the management of partial thickness burns: results of a clinical study.  J Burn Care Rehabil. 2007;  , in press
• 9 Horch RE, Jeschke MG, Spilker G, Herndon DN, Kopp J. Treatment of second degree facial burns with allografts - preliminary results.  Burns. 2005;  31 597-602
• 10 Lal S, Barrow RE, Wolf SE, Chinkes DL, Hart DW, Heggers JP, Herndon DN. Biobrane^® improves wound healing in burned children without increased risk of infection.  Shock. 2000;  14 314-319
• 11 Quinby WCJ, Hoova HC, Scheflan M, Wolters PT, Slavin SA, Boudoc CC. Clinical trials of amniotic membranes in burn wound care.  Plast Reconstr Surg. 1982;  70 711-717
• 12 Rennekampf HO. Tissue Engineering und Hautersatz nach großflächigen Verbrennungen und Verletzungen.  aesthetic TRIBUNE. 2006;  6 10
• 13 Smith DJ, Thomson PD, Bolton LL, Hutchinson JJ. Microbiology and healing of the occluded skin-graft donor site.  Plast Reconstr Surg. 1993;  91 1094-1097
• 14 Staso MA, Raschbaum M, Slater H, Goldfarb IW. Experience with Omiderm^® - a new burn dressing.  J Burn Care Rehabil. 1991;  12 209-210
• 15 Stassen NA, Lukan JK, Mizuguchi NN, Spain DA, Carillo EH, Polk HC. Thermal injury in the elderly: when is comfort care the right choice.  Am Surg. 2001;  67 704-708
• 16 Still J, Glat P, Silverstein P, Griswold J, Monzingo D. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients.  Burns. 2003;  29 837-841
• 17 Uhlig C, Rapp M, Hartmann B, Hierlemann H, Planck H, Dittel KK. Suprathel^® - an innovative, resorbable skin substitute for the treatment of burn injury victims.  Burns. 2007;  33 221-229
• 18 Vloemans AFPM, Middelkoop E, Kreis RW. A historical appraisal of the use of cryopreserved and glycerol-preserved allograft skin in the treatment of partial thickness burns.  Burns. 2002;  28 16-20
• 19 Vogt PM, Reimer K, Hauser J, Roßbach O, Steinau HU, Bosse B, Muller S, Schmidt T, Fleischer W. PVP-iodine in hydrosomes and hydrogel - A novel concept in wound therapy leads to enhanced epithelization and reduced loss of skin grafts.  Burns. 2006;  32 698-705
• 20 Wolf SE. The major burn. In: Barret-Nerín JP, Herndon DN (eds.). Principles and Practice of Burn Surgery. Marcel Dekker, New York 2005: 221-248
• 21 Wou XW, Herndon DN, Spies M, Sanford AP, Wolf SE. Effects of delayed wound excision and grafting in severly burned children.  Arch Surg. 2002;  137 1049-1054
• 22 Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of Acticoat Antimicrobial Barrier Dressing.  J Burn Care Rehabil. 1999;  20 195-200

Correspondence